Research graph
References from Challenge in the Laboratory Diagnosis of Acquired Factor VIII Inhibitor With Concurrent Lupus Anticoagulant: A Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1111/ijlh.14344
10.1111/ijlh.14344 · External reference
Avoiding Errors in the Laboratory Evaluation of Potent Lupus Anticoagulants
10.1002/ajh.21666 · 2010 · External reference
Impact of Different Factor VIII Inhibitor Kinetic Profiles on the Inhibitor Titer Quantification Using the Modified Nijmegen–Bethesda Assay
10.1002/rth2.12799 · 2022 · External reference
Inactivation of Factor VIII Coagulant Activity by Two Different Types of Human Antibodies
10.1182/blood.v60.5.1103.1103 · 1982 · External reference
10.1046/j.1365‐2141.2001.03067.x
10.1046/j.1365‐2141.2001.03067.x · External reference
A Chromogenic Substrate Method for Detecting and Titrating Anti‐Factor VIII Antibodies in the Presence of Lupus Anticoagulant
2002 · External reference
Bleeding in Carriers of Hemophilia
10.1182/blood-2005-09-3879 · 2006 · External reference
Regulation and Importance of Factor VIII Levels in Hemophilia A Carriers
10.1097/moh.0000000000000667 · 2021 · External reference
Moderate X‐Chromosome Inactivation Skewing Underlies Factor VIII Activity in Symptomatic Carriers From a Family With Mild Haemophilia A
10.1111/hae.13083 · 2016 · External reference
X Chromosome Inactivation: A Modifier of Factor VIII and IX Plasma Levels and Bleeding Phenotype in Haemophilia Carriers
10.1038/s41431-020-00742-4 · 2021 · External reference
Nonrandom X‐Inactivation Patterns in Normal Females: Lyonization Ratios Vary With Age
10.1182/blood.v88.1.59.59 · 1996 · External reference
Emicizumab Prophylaxis in Patients With Acquired Haemophilia A (GTH‐AHA‐EMI): An Open‐Label, Single‐Arm, Multicentre, Phase 2 Study
10.1016/s2352-3026(23)00280-6 · 2023 · External reference
Lupus Anticoagulant and Antiprothrombin Antibodies: Embracing the Future
10.1016/j.jtha.2025.03.029 · 2025 · External reference
Laboratory Testing for Factor VIII and IX Inhibitors in Haemophilia: A Review
10.1111/hae.13424 · 2018 · External reference
The Spectrum of Neutralizing and Non‐Neutralizing Anti‐FVIII Antibodies in a Nationwide Cohort of 788 Persons With Hemophilia A
10.3389/fimmu.2024.1355813 · 2024 · External reference
